A Study of Bezafibrate in Mitochondrial Myopathy
A Feasibility Study of Bezafibrate in Mitochondrial Myopathy
Sponsor: Newcastle University
A PHASE2 clinical study on Mitochondrial Diseases, this trial is completed. The trial is conducted by Newcastle University and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Feb 2017 — Oct 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Newcastle University
- Newcastle-upon-Tyne Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Newcastle upon Tyne, United Kingdom